Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > July 2012

« Previous month Next month »

Catalent plans single use overhaul of bioreactors

31-Jul-2012 - Catalent has replaced all stainless steel bioreactors at its biologics facility in Middleton, Wisconsin with single-use techs citing cost and flexibility advantages.

Ricerca launches two new in vitro assays including cytokine storm test

31-Jul-2012 - US Preclinical CRO Ricerca has launched two new assay services one of which is designed to help assess the risk a biologic drug will induce a cytokine storm. 

BioFocus and Activiomics team up to boost drug candidate selection

31-Jul-2012 - BioFocus and Activiomics have teamed up to offer a drug discovery and biomarker service which it says will improve the identification of novel targets.

GVK gets facility OK; ClinTec expands in Africa

30-Jul-2012 - Developments in the CRO sector continue despite the summer vacation season with news from GVK Biosciences and ClinTec International.

News in brief

Quintiles to promote Almirall's COPD drug in UK

30-Jul-2012 - Spanish pharmaceutical firm Almirall has called on Quintiles to help promote its respiratory drug portfolio in the UK.

Payment based on CRO results is the wave of the future: iGate

30-Jul-2012 - Outcome-based payment for CRO services is the “wave of the future” for pharmaceutical outsourcing, according to iGate.


Covance's flagging early phase biz puts downer on net profits in Q2

26-Jul-2012 - Covance has reported a net loss of $12.7m in this year’s Q2 as what it says is the result of facility closures and restructuring costs, particularly for its early phase...

PCORI says Pharmas may bias trials

26-Jul-2012 - The US Patient-Centered Outcomes Research Institute (PCORI) has suggested the pharmaceutical industry is introducing bias into clinical trials through selective use of inclusion/exclusion criteria and comparators.

News in brief

Beta Pharma lands cancer drug manufacturing and development contract

25-Jul-2012 - Beta Pharma Canada will produce a batch of adva-27a, a developmental cancer drug being developed by Sunshine Biopharma.

CMO pharma biz set to boom thanks to uptick in Asian activities

25-Jul-2012 - The global CMO market will grow from $26bn in 2010 to $59.9bn by 2018 thanks to a boom in the amount of work outsourced to the Asia market, says GBI Research.

Parexel backs EU trial laws changes but wants faster implementation

24-Jul-2012 - Parexel says EU trials directive never achieved harmonization aims and welcomes plans to simplify regulations, even if the implementation date is further away than expected.

Icon takes Q2 operating hit thanks to $5.6m restructuring charges

24-Jul-2012 - Icon’s operating profits have dropped by almost half since last year as a result of a $5.6m payout related to restructuring costs.


All Indian pharmaceutical CMOs must pay the excise duty, says SPIC

23-Jul-2012 - SPIC has pressed the Indian PM to issue a standardised excise duty to all contract manufacturers operating in the country so drugsmakers can have a level playing field.

Parexel teams with KDDF

23-Jul-2012 - The billion dollar Korea Drug Development Fund (KDDF) has called on US CRO Parexel to help local developers commercialise pharmaceuticals on the global market.

News in brief

Reports suggest Covance has sold its shares in Caprion

23-Jul-2012 - Reports suggest Covance has sold its minority stake in biomarker service firm Caprion Proteomics which has been acquired by Chicago Growth Partners.

News from Parexel, Ricerca, and CSC – People on the move

23-Jul-2012 - presents its weekly low down of the movers and shakers in the world of pharmaceuticals, including news from Parexel, Ricerca, and CSC.

Poll closes 31/07/12

CRO Poll: What do you think of proposed changes to EU trial laws?

19-Jul-2012 - The EC says proposals to replace the Clinical Trials Directive with simplified rules will make Europe more attractive for trials, but what do CROs think? Share your opinions in this...

ScinoPharm wins API contract for new US obesity drug Qsymia

19-Jul-2012 - Approval of Qsymia - Vivus’ anti-obesity drug – may be good news for the 35 per cent of US citizens classed as obese , but it is definitely good news for...

EC adopts plan to change trial rules, yet to decide on non-EU inspections

18-Jul-2012 - European lawmakers still need to decide how to inspect clinical trials in non-EU countries under proposed regulatory reforms adopted by the EC.

News from PPD, Parallon, ShangPharma and C3i – People on the move

18-Jul-2012 - presents the latest in the busy world of pharmaceutical careers, including news from PPD, Parallon, ShangPharma and C3i.

Indian API production takes hit as APPCB shuts 12 plants

18-Jul-2012 - API production in India will take a hit this week with plant closures for Aurobindo, Hetero Drugs, Divis Pharmaceuticals, and Sri Krishna Pharmaceuticals following allegations of environmental wrongdoing.

BioFocus gives itself room to update compound library

17-Jul-2012 - BioFocus has taken on Titian’s sample management software in a bid to pump more resources into “refreshing” its 900,000 strong high-throughput screening (HTS) compound portfolio.

DSM's CMO biz wins second contract in two months

17-Jul-2012 - DSM Pharmaceutical Products (DPP) has won its second biologics manufacturing contract in two months signing up Brazil’s Recepta Biopharma as a new customer.

Medpace doubles early-phase capacity with a new clinical pharmacology unit

17-Jul-2012 - Ohio, US-based CRO Medpace says it has finished work on a new pharmacology unit in Cincinnati and plans to close its old facility in Norwood.

« Previous month Next month »

Key Industry Events


Access all events listing

Our events, Shows & Conferences...